Viewing Study NCT05123534

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-03-08 @ 3:35 AM
Study NCT ID: NCT05123534
Status: SUSPENDED
Last Update Posted: 2024-09-19
First Post: 2021-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG
Sponsor: SonALAsense, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Intrinsic Pontine Glioma View
None Diffuse Midline Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DIPG View
None Sonodynamic Therapy View
None Exablate 4000 Type 2.0 View
None MR-guided Focused Ultrasound View
None SONALA-001 View
None SDT View
None MRgFUS View
None Aminolevulinic acid HCI View
None ALA HCI View
None ALA View
None DMG View